Rutgers Cancer Institute of New Jersey
72
3
10
36
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 80/100
36.1%
26 terminated/withdrawn out of 72 trials
58.1%
-28.5% vs industry average
1%
1 trials in Phase 3/4
86%
31 of 36 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (72)
Autologous Stem Cell Transplant With Pomalidomide (CC-4047®) Maintenance Versus Continuous Clarithromycin/ Pomalidomide / Dexamethasone Salvage Therapy in Relapsed or Refractory Multiple Myeloma
Role: collaborator
Proton Therapy vs. IMRT for Low or Intermediate Risk Prostate Cancer
Role: collaborator
A Study of Atezolizumab and Bevacizumab in Hepatocellular Carcinoma
Role: collaborator
The IDEA Study (Individualized Decisions for Endocrine Therapy Alone)
Role: collaborator
Perfusion Magnetic Resonance Imaging in Diagnosing Patients With Kidney Tumors
Role: collaborator
Targeted Genomic Analysis of Blood and Tissue Samples From Patients With Cancer
Role: collaborator
Estrogen, Diet, Genetics and Endometrial Cancer
Role: collaborator
Molecular Studies and Clinical Correlations in Human Prostatic Disease
Role: collaborator
A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients With Recurrent Small Cell Lung Cancer
Role: collaborator
A Multilevel Intervention to Improve Timely Cancer Detection and Treatment Initiation
Role: collaborator
Pembrolizumab, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Stage II-IIIB Non-Small Cell Lung Cancer
Role: collaborator
Study of Bacillus Calmette-Guerin (BCG) Combined With PANVAC Versus BCG Alone in Adults With High Grade Non-Muscle Invasive Bladder Cancer Who Failed At Least 1 Course of BCG
Role: collaborator
Bright Ideas - CIN Feasibility Study
Role: collaborator
International PPB/DICER1 Registry
Role: collaborator
Cetuximab Before Surgery in Treating Patients With Aggressive Locally Advanced Skin Cancer
Role: collaborator
Phase I/II Trial of Letrozole and Sorafenib in Post-Menopausal Hormone-Receptor + Breast Cancer
Role: collaborator
Radiation Therapy in Treating Women With Early Stage Breast Cancer
Role: collaborator
High-Dose Aldesleukin and Ipilimumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed By Surgery
Role: collaborator
Accelerated Partial Breast Radiation Therapy Using High-Dose Rate Brachytherapy in Treating Patients With Early Stage Breast Cancer After Surgery
Role: collaborator
Accelerated Radiation Therapy After Surgery in Treating Patients With Breast Cancer
Role: collaborator